OpenAlex
PricingAboutJobs
Log inGet started
Work

Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)

HTML PDF

Year: 2010
Type: article
Study design: Clinical Trial
Source: Annals of the Rheumatic Diseases
DOI: 10.1136/ard.2010.139725
Authors: Gerd R Burmester, E Feist, H Kellner, J Braun, C Iking-Konert, A Rubbert-Roth
Institutions: Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, Rheumazentrum Ruhrgebiet, University Medical Center Hamburg-Eppendorf, University of Cologne
Language: English

Topic: Rheumatoid Arthritis Research and Therapies
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: tocilizumab, rheumatoid arthritis, IL-6 receptor inhibitor, real-world effectiveness, safety, rheumatoid factor, disease activity remission, C-reactive protein, adverse events, serious infections, morning stiffness, pain, biologic therapy
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W2113018560
FWCI: 9.792
Cites: 17
Cited by: 172
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms